GlassScriptPhysician profile
Robert H Zax
NPI 1689659781
$6,382.88
in general payments reported to CMS, 2019-2025
35 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $990 · 2021: $736 · 2022: $1,274 · 2023: $1,490 · 2024: $565 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,441 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,441.21 |
| Education | $105.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,682.79 | 2019-2025 | Rinvoq, Skyrizi, Botox |
| Merz North America, INC. | $1,531.44 | 2019-2023 | Xeomin |
| Novartis Pharmaceuticals Corporation | $657.17 | 2019-2025 | |
| Janssen Biotech, INC. | $287.79 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $262.23 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Genentech USA, INC. | $247.51 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $174.36 | 2019-2025 | Absorica Ld, Winlevi, Blu-U |
| Leo Pharma INC. | $144.45 | 2019-2022 | |
| Amgen INC. | $124.94 | 2019-2024 | Otezla |
| Epi Health, LLC | $118.95 | 2019-2021 | |
| Biofrontera INC. | $116.20 | 2019-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Almirall LLC | $112.35 | 2021-2025 | Klisyri, Seysara |
| Organogenesis INC. | $108.94 | 2022-2023 | Puraply |
| Galderma Laboratories, L.P. | $107.45 | 2020-2025 | Aklief, Nemluvio |
| Dermavant Sciences, INC. | $88.24 | 2023 | Vtama |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $79.02 | 2022-2024 | Opzelura |
| Pfizer INC. | $76.65 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $72.02 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $62.43 | 2023-2024 | Sotyktu |
| Genzyme Corporation | $56.76 | 2019-2025 | |
| Mimedx Group, INC. | $36.69 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.54 | 2024 | Spevigo |
| Dusa Pharmaceuticals, INC. | $23.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.93 | 2020 | |
| Mayne Pharma Commercial LLC | $20.34 | 2020 | |
| Organon LLC | $17.22 | 2025 | Vtama |
| Sebela Pharmaceuticals INC. | $15.89 | 2020 | |
| Vyne Pharmaceuticals INC. | $15.72 | 2021 | |
| Dermira, INC. | $15.46 | 2019 | |
| Prugen, INC. Pharmaceuticals | $14.12 | 2019 | |
| Arcutis Biotherapeutics, INC. | $13.78 | 2023 | |
| Journey Medical Corporation | $13.59 | 2024 | |
| Misonix INC | $12.69 | 2019 | |
| Merck Sharp & Dohme LLC | $12.62 | 2019 | |
| Strata Skin Sciences, INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Zax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.